Cardiac Linear and Torsional Contractility Measurements With a New Technology: Multi Dimensional Kineticardiography

Validation Study of Cardiac Linear and Torsional Contractility Measurements With a New Technology: Multi Dimensional Kineticardiography (MKCG)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03107351

Acronym

MultiKinVal

Enrollment

Registered

2017-04-11

Start date

2017-03-27

Completion date

2018-02-01

Last updated

2018-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

This study aims to validate the possibility to track cardiac contractility changes with a new technology called 'Heart Kinetic' (HK). HK measurements will be realized and compared echocardiography.

Interventions

DEVICECardiac contractility assessments with Kino-cardiograph

Cardiac contractility will be assessed with Kino-cardiograph device. Echocardiography will also be used for the experimental arm

DEVICECardiac assessment repeatability with Kino-cardiograph

Cardiac contractility will be assessed with Kino-cardiograph device only, at different times of the day to assess the repeatability of the measures.

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

DEVICE_FEASIBILITY

Masking

DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Double blind randomized crossover active vs placebo

Eligibility

Sex/Gender

ALL

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Adult between 18 and 50 years old. * Healthy without medical cardiac conditions history. * Non smoker. * Does not take any drugs or medications. * Does not participate in other clinical study or trial. * BMI (Body Mass Index) in between 20 and 25 kg/m2.

Exclusion criteria

* Being younger than 18 or older than 50 years old. * Having had previous cardiac conditions or present disease. * Being a regular smoker. * Taking any drugs or medications * Taking part in another clinical study or trial. * BMI (Body Mass Index) lower than 20 or higher than 25 kg/m2.

Design outcomes

Primary

Measure	Time frame	Description
HK reproducibility validation	day 1	Validate the reproducibility of HK measurements in a clinical environment.
Cardiac contractility tracking with HK	day 1	Proof that the HK technology can track physiological cardiac changes while comparing with gold standard echocardiography and inducing a cardiac contractility change with dobutamine infusion.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026